Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of cancellation of admission to AIM

13 Nov 2017 07:00

RNS Number : 2415W
Touchstone Innovations PLC
13 November 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

13 November 2017

Touchstone Innovations plc

 

Notice of cancellation of admission to trading on AIM

 

Further to the announcement released on 18 October 2017 by IP Group plc ("IP Group") declaring the IP Group offer (the "Offer") wholly unconditional in all respects, Touchstone Innovations plc ("Touchstone" or the "Company") notifies its shareholders that, at the request of IP Group, an application has been made to London Stock Exchange plc to cancel the trading facility in the ordinary shares in the capital of the Company ("Ordinary Shares") on AIM with effect from 7:00am on 11 December 2017.

The cancellation of trading in the Ordinary Shares will significantly reduce the liquidity and marketability of any Ordinary Shares and, as previously stated, the Board of Touchstone recommends that Touchstone shareholders who have not yet accepted the Offer now do so promptly.

Those Touchstone shareholders who accept the Offer will receive their new shares in IP Group as consideration for their Touchstone shares at an earlier date than they would as part of the compulsory acquisition procedure.

IP Group has announced that the Offer will remain open until further notice and that not less than 14 calendar days' notice will be given in respect of the closure of the Offer.

If you are a Touchstone shareholder and in any doubt as to the action you should take, you are recommended to seek your own financial advice immediately from your stockbroker, bank manager, solicitor, accountant, fund manager or other appropriate independent financial adviser authorised under the Financial Services and Markets Act 2000, as amended if you are resident in the United Kingdom or, if not, from another appropriately authorised independent financial adviser.

For further information contact:

Touchstone Innovations plc

020 3053 8834

Russ Cummings, Chief Executive Officer

William Rayner, General Counsel and Company Secretary

Jon Davies, Director of Communications

Instinctif Partners

020 7457 2020

Adrian Duffield/Mel Toyne-Sewell/Chantal Woolcock

J.P. Morgan Cazenove (Nominated adviser)

020 7742 4000

Michael Wentworth-Stanley/Alec Pratt

RBC Capital Markets (Joint Corporate Broker)

020 7653 4000

Marcus Jackson

 

Further Information

J.P. Morgan Limited, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), is authorised and regulated in the United Kingdom by the Financial Conduct Authority. J.P. Morgan Cazenove is acting as financial adviser exclusively for Touchstone Innovations plc and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than Touchstone Innovations plc for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, or for providing advice in relation to any matter referred to herein.

RBC Capital Markets is the business name used by RBC Europe Limited, which is authorised in the United Kingdom by the Prudential Regulation Authority ("PRA") and regulated by the Financial Conduct Authority and the PRA and is a subsidiary of the Royal Bank of Canada. RBC is acting as Corporate Broker to the Company.

 

Ends

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPFEFDSXFFF
Date   Source Headline
24th Jan 20117:00 amRNSResult of equity raise
6th Jan 20111:11 pmRNSResult of General Meeting
9th Dec 201011:10 amRNSDirectors' Dealings
8th Dec 20104:55 pmRNSPublication of Prospectus
7th Dec 20107:09 amRNS£140m equity raising
12th Oct 20107:00 amRNSFinal Results
15th Sep 20104:17 pmRNSNotice of Results
2nd Sep 20109:00 amRNSPortfolio News
25th Aug 20109:00 amRNSPortfolio Company News
20th Aug 20109:00 amRNSFurther portfolio investments
22nd Jun 201010:37 amRNSDirectors' Dealings
1st Jun 20107:01 amRNSSale of portfolio company
27th Apr 20107:00 amRNSInterim Results
23rd Apr 20109:05 amRNSMIT praises Novacem technology
9th Apr 20107:00 amRNSNotice of Results
6th Apr 20108:00 amRNSInvestment in portfolio company
11th Mar 20108:00 amRNSFurther Investment in portfolio company
8th Mar 20104:19 pmRNSChange of Adviser
5th Mar 201011:05 amRNSTR1 - Notification of major interest in shares
3rd Mar 20108:30 amRNSMilestone for Nexeon
2nd Mar 20107:16 amRNSMembrane Extraction Technology sold
1st Mar 20107:00 amRNSInvestment in portfolio company
17th Feb 20107:00 amRNSFurther Investment In PolyTherics
8th Feb 201012:41 pmRNSDirector Dealing
5th Feb 20103:42 pmRNSNotification of Major Interest in Shares
27th Jan 20107:00 amRNSLicence Agreement
19th Jan 20105:58 pmRNSDirector Dealings
19th Jan 201011:47 amRNSAdditional Listing of Shares
21st Dec 200911:32 amRNSBoard Appointment
15th Dec 200912:04 pmRNSResult of AGM
11th Dec 20097:00 amRNSFurther investment in portfolio company
8th Dec 200910:14 amRNSDirector Dealing's
27th Nov 200910:31 amRNSHolding(s) in Company
11th Nov 200911:42 amRNSNotice of AGM
21st Oct 20093:20 pmRNSDirector Dealings
20th Oct 20097:00 amRNSFurther Investment In Portfolio Company
13th Oct 20094:17 pmRNSDirector Dealing
12th Oct 20093:09 pmRNSDirectors' Dealings
8th Oct 20097:00 amRNSFurther Investment in Plaxica
7th Oct 20097:00 amRNSFinal Results
21st Sep 20097:00 amRNSInvestment in Portfolio Company
1st Sep 20097:00 amRNSLeads ?2 funding round in Molecular Vision
25th Aug 20093:30 pmRNSNotice of Results
10th Aug 20097:00 amRNSInvestments in portfolio companies
3rd Jul 20097:00 amRNSInvestment in OSspray
26th Jun 20097:00 amRNSDisposal of investment in InforSense
2nd Jun 20094:30 pmPRNHolding(s) in Company
28th May 20098:05 amRNSPortfolio Company IP Trade Sale to Technip
20th May 20097:00 amRNSDirector/PDMR Shareholding
27th Apr 20097:00 amPRNHalf-yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.